FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 16, 2004

 

 

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 

 

Delaware   1-16671   23-3079390

(State or Other Jurisdiction of

Incorporation or Organization)

   Commission File Number  

(I.R.S. Employer

Identification Number)

 

1300 Morris Drive Chesterbrook, PA   19087
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (610) 727-7000

 

N/A
(Former name or former address, if changed since last report.)

 

Item 5. Other Events.

 

On July 16, 2004, AmerisourceBergen Corporation (the “Registrant”) issued a news release announcing a pharmaceutical distribution agreement with Kaiser Permanente. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.

 

Item 7. Financial Statements and Exhibits.

 

  (c) Exhibits.

 

  99.1 News Release dated July 16, 2004

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

AMERISOURCEBERGEN CORPORATION

Date: July 16, 2004

  

By:

  

/s/ Michael D. DiCandilo

   

Name:

  

Michael D. DiCandilo

   

Title:

  

Senior Vice President and Chief Financial Officer